We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NASOSENSE ALLERGY (Neo Health (OTC) Pty Ltd)
Product name
NASOSENSE ALLERGY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
124 (255 working days)
Active ingredients
mometasone furoate monohydrate
Registration type
New generic medicine
Indication
For the prophylaxis or treatment of allergic rhinitis for up to six months in adults and children 12 years of age and over